💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…
Profile for ACADIA Pharmaceuticals Inc. (ACAD)
« Back to company indexACAD Chatter Timeline
Stock Ticker for ACAD
Most Active Tweeters for ACAD
| User | Tweets |
|---|---|
| @Biotech2050 | 8 |
| @mediasentiment | 7 |
| @formwhisperscom | 6 |
| @fintel_io | 6 |
| @InsiderAlerts4U | 6 |
Recent Tweets for ACAD
 |
@ChartMill $ACAD forming an excellent breakout setup pattern. https://t.co/juS40KUxBn January 20th 2021, 3:01am |
 |
@Soudesu9 $acad decent number of April $45 puts today...hedge?? January 19th 2021, 5:01pm |
 |
@Gambiste1 RT @Traders_Eye1: $ACAD: another Cup and Handle with a bull flag. Not a stock I found but saw here on Twitter https://t.co/YfpxzXJq9z January 18th 2021, 4:01pm |
 |
@Traders_Eye1 $ACAD: another Cup and Handle with a bull flag. Not a stock I found but saw here on Twitter https://t.co/YfpxzXJq9z January 18th 2021, 3:01pm |
 |
@SwingTradeBot Recent $ACAD technical alerts: Fell Below 20 DMA plus 7 more alerts... https://t.co/bE2LrE6Q53 January 18th 2021, 2:01pm |
|
@Gambiste1 RT @semodough: $ACAD Nuplazid’s visible TRx’s from IQVIA are up this week (while NRx are flat) and have been volatile though trends showing… January 17th 2021, 5:01am |
 |
@semodough $ACAD Nuplazid’s visible TRx’s from IQVIA are up this week (while NRx are flat) and have been volatile though trend… https://t.co/S6NZbHNMjT January 17th 2021, 2:01am |
 |
@JFDI $acad 3wt January 16th 2021, 6:01pm |
 |
@MarcJacksonLA $ACAD RBC Capital Maintains Buy Rating On Acadia Pharmaceuticals, $60 PT https://t.co/7RizafBZHc January 15th 2021, 4:01pm |
|
@MarcJacksonLA $ACAD JP Morgan Maintains Buy Rating On Acadia Pharmaceuticals https://t.co/MWxVCgqSkf January 15th 2021, 4:01pm |
 |
@QuantchaIdeas Covered Call Alert: ACADIA PHARMACEUTICALS $ACAD returning up to 22.71% through 18-Jun-2021 https://t.co/VNJBasXj0y January 15th 2021, 3:01pm |
 |
@insiderbuyings $ACAD new insider selling: 700 shares. https://t.co/Qo7kHjXWsr January 15th 2021, 6:01am |
 |
@InsiderAlerts4U $ACAD: New Insider Filing on ACADIA PHARMACEUTICALS INC's President SRDJAN R. STANKOVIC: https://t.co/8fgAhDqiT5 January 15th 2021, 1:01am |
 |
@fintel_io Insider Stankovic Srdjan R. reports selling 700 shares of $ACAD for a total cost of $38,507.00 https://t.co/fhedI8mxC2 January 15th 2021, 12:01am |
 |
@FlashAlert_me $ACAD [15s. delayed] filed SEC form 4: President Stankovic Srdjan R.: Disposed 700 of Common Stock at price $55.01… https://t.co/iI4CrS0amU January 15th 2021, 12:01am |
 |
@formwhisperscom #FWSells $ACAD Stankovic Srdjan R., President of ACADIA PHARMACEUTICALS INC sold 700 shares on 2021-01-12. https://t.co/XTJBeFteQG January 15th 2021, 12:01am |
 |
@ForTheRecord01 $ACAD Nothing on the FDA's calendar for February indicates an advisory committee hearing for Nuplazid/DRP. In ligh… https://t.co/ZxcUIQh8ig January 14th 2021, 7:01am |
|
@ForTheRecord01 $ACAD Short interest fell nearly 700,000 shares in the last 2 weeks of December; it now stands at an all-time low.… https://t.co/ofCIaD4BeF January 14th 2021, 7:01am |
|
@tparodi1 @hnrtrading $ACAD really nice looking c&h on 6mo daily. I am long a starter. January 13th 2021, 4:01pm |
 |
@ResearchPool $ACAD #AcadeMedia AB ... Northern Lights: [...] https://t.co/E5ZNFA9jrj January 13th 2021, 7:01am |
 |
@Biotech2050 $ACAD #JPM21 At minute 15:01 the CEO said that nuplazid has the potential to help millionS of patients and their l… https://t.co/Hvm1ijzZoW January 13th 2021, 6:01am |
 |
@rmacmillan310 $ACAD here we go!! 2.43 % change recently https://t.co/a76nnZvf6v January 13th 2021, 6:01am |
|
@Biotech2050 $ACAD #JPM21 Similarities and differences between PDP & DRP https://t.co/6nqdX9FysI January 13th 2021, 6:01am |
|
@Biotech2050 $ACAD #JPM21 #dementia patients are x2 more costly ($90K) within 1st year of diagnosis of psychosis https://t.co/JTVlYZg0bY January 13th 2021, 6:01am |
|
@Biotech2050 $ACAD #JPM21 Pimavanserin was associated with REDUCED all-cause mortality compared to atypical antipsychotics https://t.co/7LQGnVS4im January 13th 2021, 6:01am |
|
@Biotech2050 $ACAD #JPM21 Strong commercial execution in PDP https://t.co/mui0fMUfZy January 13th 2021, 6:01am |
|
@Biotech2050 Finally listening to the #JPM21 $ACAD webcast (it was at the same time as $TGTX presentation) The dementia related… https://t.co/0HcQSdmAIg January 13th 2021, 6:01am |
|
@Biotech2050 RT @semodough: $ACAD mgt Nuplazid sNDA in dementia-related psychosis (DRP) by PDUFA date April 3rd. DRP is 10x size of the currently approv… January 13th 2021, 4:01am |
|
@semodough $ACAD mgt Nuplazid sNDA in dementia-related psychosis (DRP) by PDUFA date April 3rd. DRP is 10x size of the current… https://t.co/AfxLulsf6v January 13th 2021, 2:01am |
|
@ResearchPool $ACAD #AcadeMedia AB AcadeMedia AB (Buy, TP: SEK110.00) - Adding to its acquisition credentials: We expect Q2 reven… https://t.co/N63d6xASMQ January 12th 2021, 11:01pm |
 |
@Beeken_health $ACAD - ACADIA Pharmaceuticals Inc.'s (ACAD) CEO Stephen Davis at 39th Annual J.P. Morgan Healthcare Conference (Tr… https://t.co/x8dDgDrdYf January 12th 2021, 10:01pm |
 |
@SeekingAlpha $ACAD - ACADIA Pharmaceuticals Inc.'s (ACAD) CEO Stephen Davis at 39th Annual J.P. Morgan Healthcare Conference (Tr… https://t.co/P7cFN419M0 January 12th 2021, 10:01pm |
|
@rmacmillan310 $ACAD exactly don't sell -3.38 % change recently https://t.co/a76nnZvf6v January 12th 2021, 8:01pm |
|
@SeekingAlpha $ACAD - JP Morgan Presentation 2021. https://t.co/pvqp40982m #stocks #markets #stockmarket January 12th 2021, 5:01pm |
 |
@BlueBioNow $ACAD the valuation looks good ?????????????? 2.39 % change recently https://t.co/1zSvnNjMxb January 12th 2021, 8:01am |
|
@Gambiste1 RT @ForTheRecord01: $ACAD The slide presentation for the JP Morgan Conference is already on the company website: https://t.co/XN9fDggKPX C… January 12th 2021, 7:01am |
|
@BlueBioNow $ACAD auction is now open. -3.38 % change recently https://t.co/1zSvnNjMxb January 12th 2021, 4:01am |
|
@ForTheRecord01 $ACAD The slide presentation for the JP Morgan Conference is already on the company website:… https://t.co/eIDrThCidA January 11th 2021, 8:01pm |
|
@FlashAlert_me $ACAD [15s. delayed]: Issued Press Release on January 11, 13:31:00: Shuman Glenn & Stecker Investigates Acadia… https://t.co/pVmKbjAtJs January 11th 2021, 6:01pm |
 |
@Tickeron 5 Insiders at Acadia Pharmaceuticals sold 99,375 shares last week for $5.5M $ACAD #AcadiaPharmaceuticals… https://t.co/2gJdE1ykNO January 11th 2021, 5:01pm |
|
@rmacmillan310 $ACAD Lets see how this turns out -3.38 % https://t.co/a76nnZvf6v January 11th 2021, 2:01pm |
 |
@JBMGStockTrades Rebought $PLAN, sold $ACAD for half loss January 11th 2021, 2:01pm |
 |
@gcassidy718 $ACAD Valuation is starting to make more sense now $47.82. https://t.co/5rGAHkRyvb January 11th 2021, 8:01am |
|
@ForTheRecord01 $ACAD The note below, written by Jefferies analyst Chris Howerton last summer, is as fine an encapsulation of Acadi… https://t.co/juY8pFC01O January 11th 2021, 4:01am |
 |
@MarketChmln $ACAD upcoming event January 12: 39th Annual J.P. Morgan Healthcare Conference. Options expiring on January 15 that… https://t.co/q3OnnduUXn January 11th 2021, 3:01am |
|
@gcassidy718 $ACAD definitely going to finish under $47.82 -3.38 % change recently https://t.co/5rGAHkRyvb January 10th 2021, 8:01pm |
|
@BlueBioNow $ACAD Needs to rebound at some point -3.38 % change recently https://t.co/1zSvnNjMxb January 10th 2021, 3:01pm |
 |
@mediasentiment $ACAD new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 137 January 10th 2021, 11:01am |
|
@mediasentiment $ACAD new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 136 January 10th 2021, 11:01am |
|
@BlueBioNow $ACAD I’ll probably buy on the dip. Still need to do more research. -3.38 % https://t.co/1zSvnNjMxb January 10th 2021, 6:01am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2021. All rights reserved.
Get the DrugPatentWatch Daily Briefing
Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …
- ✓ Patent Expirations and Generic Entry
- ✓ 505(b)(2) & Biosimilars
- ✓ Insightful Articles and Case Studies
- ✓ Patent Litigation & Challenges
- ✓ Industry Trends
